Truenorth Lifesciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Truenorth lifesciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Truenorth Lifesciences Today - Breaking & Trending Today

Enalare Therapeutics Completes Formation of Its Scientific Advisory Board


Enalare Therapeutics Completes Formation of Its Scientific Advisory Board
Posted Jan 13, 2021
The Appointments of Professors Albert Dahan MD, PhD and Tong Joo (TJ) Gan MD, MHS, MBA  Highlight a World Class Collection of Medical and Pharmaceutical Industry Experts 
PRINCETON, N.J., January 12, 2021 – Enalare Therapeutics Inc., a clinical stage  biopharmaceutical company dedicated to developing novel therapies for patients suffering  from acute respiratory conditions, announced today that it has completed formation of its  scientific advisory board.  The Company is very pleased to welcome Albert Dahan MD, PhD, Tong Joo (TJ) Gan MD, Robert Raffa PhD, Eugene Vortsman DO, David Battleman MD, and Alexander Krause PhD to the organization as it advances the development of its lead product ENA-001 for several life-threatening indications involving respiratory depression.  ....

New York , United States , New Jersey , Long Island , Presbyterian Hospital , Noord Holland , Truenorth Lifesciences , Herm Cukier , Drexel University , University Of Cologne , Bain Company , Atlantic Pharmacology Society , Temple University School Of Medicine , Wharton School Of Business , University Of Arizona College Pharmacy , Free University , Clinical Research , Steam Co , Thomas Jefferson University , Anesthesia Pain Research Unit , Harvard School Of Public Health , Enalare Therapeutics Inc , Business Administration , University Of Pennsylvania , Business Development , Emergency Medicine Physician At Northwell Health ,

Scopus BioPharma Announces Appointment of Additional Directors


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Scopus BioPharma Announces Appointment of Additional Directors
December 29, 2020 GMT
(PRNewsfoto/Scopus BioPharma Inc.)
NEW YORK, Dec. 29, 2020 /PRNewswire/ Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers.
Joshua R. Lamstein, Chairman of Scopus BioPharma, stated, “We are delighted to be in a position to attract prominent industry leaders to our Board. Our new directors are well-recognized for their leadership and accomplishments in the biopharmaceutical, biotechnology and pharmaceutical industries, as well as in public capital markets and corporate governance.” ....

Israel General , United States , France General , United Kingdom , City Of , Rodd Leeds David Waldman , Scopus Biopharma , Lesley Russell , Robertson Stephens , Eli Lilly , Zealand Pharma , Truenorth Lifesciences , Davida Buckel , Joshuar Lamstein , Raphael Rafi Hofstein , Davids Battleman , Department Of Neurobiology At Harvard Medical School , Bear Stearns , Johns Hopkins University , Scopus Biopharma Inc , Lehman Brothers , York University Stern School Of Business , Wharton School , Weild Co , Venture Services , Stockholm School Of Economics ,